Hormone releasing intrauterine system should be used more widely in primary care for menorrhagia, study concludes

In: BMJ · 2013 · vol. 346(jan09 1) , pp. f100 · doi:10.1136/bmj.f100 · PMID:23303890 · W2036925083
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-13

A two-year study found that the levonorgestrel-releasing intrauterine system provided greater improvement in bleeding and quality of life for women with menorrhagia compared to other primary care treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Women with menorrhagia reported more improvement in bleeding and quality of life with the levonorgestrel releasing intrauterine system than with other treatments available in primary care, a two year study in England has found.1 Women fitted with the levonorgestrel releasing intrauterine system (also known as LNG-IUS or Mirena) were also more likely to stick with treatment, found the study, called the Effectiveness and Cost-Effectiveness of Levonorgestrel-Containing Intrauterine System in Primary Care against Standard Treatment for Menorrhagia (ECLIPSE) study. Researchers from the Universities of Birmingham and Nottingham randomised 571 …

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK